Lupin Finalizes Patent Sale Agreement With Servier

With reference to the earlier announcement dated February 20, 2007, and pursuant to signing a definitive patent sale agreement, Lupin Ltd on April 05, 2007 has announced that the Company has received Euro 20mn from Laboratories Servier of France for the sale of certain patent applications and other related Intellectual Property for Perindopril for multiple countries.The income from this sale significantly boosts our performance for the previous quarter. It obviously goes a long way to demonstrate our Research and IP capabilities, said Dr. Kamal Sharma, Managing Director, of the Company.